Linked Life Data

15926128

Source:http://linkedlifedata.com/resource/pubmed/id/15926128

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2005-5-31
pubmed:abstractText
Alcohol withdrawal syndrome may be accompanied by severe complications, such as epileptic syndromes or delirium tremens. A number of pharmacological strategies, especially benzodiazepines (BZD), have been used in their treatment and prevention, although problems can arise from the use of these drugs due to their addictive properties. The classical anticonvulsive drugs are rarely employed as an alternative because of their side effects, but the latest generation of substances could be especially useful. AIMS. The aim of this study was to examine the safety of oxcarbazepine (OXC) in the prevention of epileptic seizures and complications deriving from the withdrawal syndrome in alcohol detoxification treatment.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0210-0010
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
577-80
pubmed:dateRevised
2009-5-28
pubmed:meshHeading
pubmed:articleTitle
[Oxcarbazepine in the prevention of epileptic syndromes in alcohol detoxification].
pubmed:affiliation
Addictive Behaviors Unit, Psychiatric Service, Hospital Universitario 12 de Octubre, Ctra. de Andalucia, E-28041 Madrid, Spain. mjimenez.hdoc@salud.madrid.org
pubmed:publicationType
Journal Article, English Abstract